Boer R - Search Results

1

No increased risk for cervical cancer after a broader definition of a negative Pap smear.

Rebolj M, van Ballegooijen M, van Kemenade F, Looman C, Boer R, Habbema JD. Rebolj M, et al. Among authors: boer r. Int J Cancer. 2008 Dec 1;123(11):2632-5. doi: 10.1002/ijc.23803. Int J Cancer. 2008. PMID: 18767046

2

Cost-effectiveness of cervical cancer screening: comparison of screening policies.

van den Akker-van Marle ME, van Ballegooijen M, van Oortmarssen GJ, Boer R, Habbema JD. van den Akker-van Marle ME, et al. Among authors: boer r. J Natl Cancer Inst. 2002 Feb 6;94(3):193-204. doi: 10.1093/jnci/94.3.193. J Natl Cancer Inst. 2002. PMID: 11830609

3

National Polyp Study data: evidence for regression of adenomas.

Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmarssen GJ, Winawer SJ, Habbema JD. Loeve F, et al. Among authors: boer r. Int J Cancer. 2004 Sep 10;111(4):633-9. doi: 10.1002/ijc.20277. Int J Cancer. 2004. PMID: 15239144 Clinical Trial.

4

How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment.

Vogelaar I, van Ballegooijen M, Schrag D, Boer R, Winawer SJ, Habbema JD, Zauber AG. Vogelaar I, et al. Among authors: boer r. Cancer. 2006 Oct 1;107(7):1624-33. doi: 10.1002/cncr.22115. Cancer. 2006. PMID: 16933324 Free article.

5

Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: Comparison of costs and side effects of three alternative strategies.

Rebolj M, Bais AG, van Ballegooijen M, Boer R, Meerding WJ, Helmerhorst TJ, Habbema JD. Rebolj M, et al. Among authors: boer r. Int J Cancer. 2007 Oct 1;121(7):1529-35. doi: 10.1002/ijc.22838. Int J Cancer. 2007. PMID: 17565745

6

At what costs will screening with CT colonography be competitive? A cost-effectiveness approach.

Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JD. Lansdorp-Vogelaar I, et al. Among authors: boer r. Int J Cancer. 2009 Mar 1;124(5):1161-8. doi: 10.1002/ijc.24025. Int J Cancer. 2009. PMID: 19048626 Free PMC article.

7

A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials.

Lansdorp-Vogelaar I, van Ballegooijen M, Boer R, Zauber A, Habbema JD. Lansdorp-Vogelaar I, et al. Among authors: boer r. Cancer. 2009 Jun 1;115(11):2410-9. doi: 10.1002/cncr.24256. Cancer. 2009. PMID: 19288570 Free PMC article.

8

Incidence of cervical cancer after several negative smear results by age 50: prospective observational study.

Rebolj M, van Ballegooijen M, Lynge E, Looman C, Essink-Bot ML, Boer R, Habbema D. Rebolj M, et al. Among authors: boer r. BMJ. 2009 Apr 24;338:b1354. doi: 10.1136/bmj.b1354. BMJ. 2009. PMID: 19395420 Free PMC article.

9

Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis.

Wilschut JA, Habbema JD, Ramsey SD, Boer R, Looman CW, van Ballegooijen M. Wilschut JA, et al. Among authors: boer r. Cancer Causes Control. 2010 Dec;21(12):2287-93. doi: 10.1007/s10552-010-9654-y. Epub 2010 Oct 28. Cancer Causes Control. 2010. PMID: 20981482 Review.

10

Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study.

Rebolj M, Helmerhorst T, Habbema D, Looman C, Boer R, van Rosmalen J, van Ballegooijen M. Rebolj M, et al. Among authors: boer r. BMJ. 2012 Oct 31;345:e6855. doi: 10.1136/bmj.e6855. BMJ. 2012. PMID: 23117059 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,559 results

Search Page

Filters